NCT04892979

Brief Summary

It is to explore the temporal relationships between physical fitness, cognitive, psychosocial functions, and health-related quality of life (HRQoL) in COVID-19 survivors over the first 15 months; and to determine the effects of centre-based (CBR), online-based cardiopulmonary rehabilitation (OBR), and combined centre- and online-based rehabilitation (COBR) on survivors with initially suboptimal pulmonary functions.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for not_applicable covid19

Timeline
Completed

Started Oct 2020

Typical duration for not_applicable covid19

Geographic Reach
1 country

4 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 1, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

May 19, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2022

Completed
Last Updated

May 19, 2021

Status Verified

February 1, 2021

Enrollment Period

1.5 years

First QC Date

March 1, 2021

Last Update Submit

May 18, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Fatigue measured by Fatigue Assessment Scale

    The Fatigue Assessment Scale is a 10-item scale evaluating symptoms of chronic fatigue.exercise test.

    6 weeks after the start of intervention

  • Fatigue measured by Fatigue Assessment Scale

    The Fatigue Assessment Scale is a 10-item scale evaluating symptoms of chronic fatigue.exercise test.

    Baseline

Secondary Outcomes (22)

  • Muscle strength by 30-second double-leg sit-to-stand test (times)

    Baseline

  • Muscle strength by 30-second double-leg sit-to-stand test (times)

    6 weeks after the start of intervention

  • Self-efficacy by 6-Item Chronic Disease Self-Efficacy scale

    Baseline

  • Self-efficacy by 6-Item Chronic Disease Self-Efficacy scale

    6 weeks after the start of intervention

  • Self-perceived quality of life by The St. George's Respiratory Questionnaire-HK version

    Baseline

  • +17 more secondary outcomes

Study Arms (3)

Centre-based

EXPERIMENTAL

Centre-based exercise cardiopulmonary rehabilitation program for 6 weeks

Other: Cardiopulmonary exercise (centre-based)

Online-based

EXPERIMENTAL

Online-based exercise cardiopulmonary rehabilitation program for 6 weeks

Other: Cardiopulmonary exercise (online-based)

Combined

EXPERIMENTAL

Combined centre- and online-based exercise cardiopulmonary rehabilitation program for 6 weeks

Other: Cardiopulmonary exercise (centre-based)Other: Cardiopulmonary exercise (online-based)

Interventions

Depending on the preference of participants, they can either choose to join three 60-minute centre-based sessions plus two sessions of 30-minute home exercise per week, or two 60-minute centre-based sessions plus four sessions of 30-minute home exercise per week. Each session will include warm-up and cool-down exercises, aerobic exercises, and progressive strengthening exercises prescribed based on individual ability (Table 1). Aerobic exercises will be performed at 60-75% (up to 85% for fit individuals) of the predicted maximum heart rate. The respective rate of perceived exertion during exercise will be maintained between 4 and 6 out of 10 on the Borg CR scale \[10\], indicating moderate to strenuous exercise levels. Additionally, physiotherapists will provide education related to COVID-19, energy conservation, and stress management during the program.

Centre-basedCombined

Participants in the OBR group will attend one face-to-face session to learn how to use a mobile application (app) followed by 6 weeks of home exercises. The online treatments will be delivered via the Caspar Health e-system, a German-designed Internet-based system, is available for desktop PCs and as a mobile app for both iOS and Android smartphones. This system will enable patients to follow their therapists' treatment plans in an asynchronous manner. The OBR programme will last for 6 weeks. Participants will be instructed to perform 40 minutes of structured exercises 6 times per week. In the first week, six 40-minute online exercise sessions will be delivered through push notifications on the mobile app.

CombinedOnline-based

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • COVID survivor at hospital discharge or 6-month post-disease onset
  • Medically stable with an Abbreviated Mental Test (AMT) scores of \> 6 out of 10

You may not qualify if:

  • Having contraindications to exercise
  • Physical Activity Readiness Questionnaire (PAR-Q) reveals unsafety
  • Cannot understand Cantonese

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Pamela Youde Eastern Hospital

Hong Kong, Hong Kong

RECRUITING

Princess Margaret Hospital

Hong Kong, Hong Kong

RECRUITING

Queen Elizabeth Hospital

Hong Kong, Hong Kong

RECRUITING

Tuen Mun Hospital

Hong Kong, Hong Kong

RECRUITING

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Siu Ngor Fu, PhD

    The Hong Kong Polytechnic University

    PRINCIPAL INVESTIGATOR
  • Loletta Kit-ying So, MD

    Pamela Youde Eastern Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Siu Ngor Fu, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 1, 2021

First Posted

May 19, 2021

Study Start

October 1, 2020

Primary Completion

March 31, 2022

Study Completion

March 31, 2022

Last Updated

May 19, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share

Locations